| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹1 -9.09% | 12,400-11.11% |
| 00% | ₹126.7 0% | 820 | ₹1.95 0% | 67,4250% |
| - | - | 840 | ₹2.35 0% | 15,5000% |
| 7750% | ₹108 0% | 850 | ₹3.2 23.07% | 24,02514.81% |
| - | - | 860 | ₹4 23.07% | 26,3506.25% |
| - | - | 870 | ₹4.4 0% | 6,9750% |
| 7750% | ₹76.15 0% | 880 | ₹6.2 20.38% | 4,60,350633.33% |
| 6,2000% | ₹68.3 0% | 890 | ₹6.25 0% | 7,7500% |
| 20,1500% | ₹67.55 0% | 900 | ₹9.65 16.26% | 2,74,35035.11% |
| 4,6500% | ₹49.35 0% | 920 | ₹14.85 16.01% | 4,03,000940% |
| 51,9251.51% | ₹37.6 -3.34% | 930 | ₹18 11.11% | 69,75069.81% |
| 24,80028% | ₹31.65 -17.47% | 940 | ₹22.5 9.75% | 1,24,00048.14% |
| 1,93,7507.75% | ₹26.4 -6.21% | 950 | ₹26.85 10.72% | 1,69,72567.17% |
| 1,50,35039.56% | ₹21.5 -8.11% | 960 | ₹32.25 9.13% | 63,5507.89% |
| 17,050120% | ₹18.45 -4.65% | 970 | ₹38 2.7% | 6,975-10% |
| 58,90049.01% | ₹15.15 -3.19% | 980 | ₹47.35 0% | 20,9250% |
| 17,825-4.16% | ₹12 -4% | 990 | ₹49.85 0% | 7750% |
| 4,47,17576.45% | ₹9.6 -3.51% | 1,000 | ₹51.25 0% | 23,2500% |
| 7750% | ₹8.4 0% | 1,010 | ₹64.45 0% | 1,5500% |
| 99,20016.36% | ₹5.35 -14.4% | 1,020 | - | - |
| 3,8750% | ₹23.15 0% | 1,030 | - | - |
| 40,3008.33% | ₹3.65 -8.75% | 1,040 | - | - |
| 34,875136.84% | ₹2.7 -12.9% | 1,050 | - | - |
| 10,0758.33% | ₹2.45 2.08% | 1,060 | - | - |
| 40,3000% | ₹1.6 0% | 1,080 | - | - |
| 3,87566.66% | ₹1.4 0% | 1,100 | - | - |
| 10,8500% | ₹1 0% | 1,120 | ₹164 0% | 3,1000% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
